Abbott Laboratories (SWX:ABT)
Switzerland · Delayed Price · Currency is CHF 93.50
0.00 (0.00%)
Sep 30, 2024, 9:05 AM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Established Pharmaceutical Products | 5.19B | Log In | Log In | Log In | Log In | Upgrade |
Established Pharmaceutical Products Growth | 2.45% | Log In | Log In | Log In | Log In | Upgrade |
Nutritionals | 8.41B | Log In | Log In | Log In | Log In | Upgrade |
Nutritionals Growth | 2.86% | Log In | Log In | Log In | Log In | Upgrade |
Diagnostics | 9.34B | Log In | Log In | Log In | Log In | Upgrade |
Diagnostics Growth | -3.50% | Log In | Log In | Log In | Log In | Upgrade |
Medical Devices | 18.99B | Log In | Log In | Log In | Log In | Upgrade |
Medical Devices Growth | 11.40% | Log In | Log In | Log In | Log In | Upgrade |
Other Segment | 16.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Segment Growth | 14.29% | Log In | Log In | Log In | Log In | Upgrade |
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Other | -3.47B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 2.25% | Log In | Log In | Log In | Log In | Upgrade |
Established Pharmaceutical Products Operating Earnings | 1.23B | Log In | Log In | Log In | Log In | Upgrade |
Established Pharmaceutical Products Operating Earnings Growth | 7.76% | Log In | Log In | Log In | Log In | Upgrade |
Nutritionals Operating Earnings | 1.51B | Log In | Log In | Log In | Log In | Upgrade |
Nutritionals Operating Earnings Growth | 14.44% | Log In | Log In | Log In | Log In | Upgrade |
Diagnostics Operating Earnings | 2.07B | Log In | Log In | Log In | Log In | Upgrade |
Diagnostics Operating Earnings Growth | -13.21% | Log In | Log In | Log In | Log In | Upgrade |
Other | -3.47B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 2.25% | Log In | Log In | Log In | Log In | Upgrade |
Medical Devices Operating Earnings | 6.15B | Log In | Log In | Log In | Log In | Upgrade |
Medical Devices Operating Earnings Growth | 14.57% | Log In | Log In | Log In | Log In | Upgrade |
Other | -3.47B | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 2.25% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 2.98% | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 2.98% | Log In | Log In | Log In | Log In | Upgrade |
United States | 16.32B | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | 8.30% | Log In | Log In | Log In | Log In | Upgrade |
Germany | 2.54B | Log In | Log In | Log In | Log In | Upgrade |
Germany Growth | - | Log In | Log In | Log In | Log In | Upgrade |
China | 2.11B | Log In | Log In | Log In | Log In | Upgrade |
China Growth | - | Log In | Log In | Log In | Log In | Upgrade |
India | 1.82B | Log In | Log In | Log In | Log In | Upgrade |
India Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Switzerland | 1.75B | Log In | Log In | Log In | Log In | Upgrade |
Switzerland Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Japan | 1.44B | Log In | Log In | Log In | Log In | Upgrade |
Japan Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Netherlands | 1.12B | Log In | Log In | Log In | Log In | Upgrade |
Netherlands Growth | - | Log In | Log In | Log In | Log In | Upgrade |
All Other Countries | 14.85B | Log In | Log In | Log In | Log In | Upgrade |
All Other Countries Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | 2.98% | Log In | Log In | Log In | Log In | Upgrade |
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Organic Sales Growth | 9.60% | Log In | Log In | Log In | Log In | Upgrade |